BIOSCIENCE HEALTH INNOVATIONS INC. (BHIC) Gross margin 2022–2025
BIOSCIENCE HEALTH INNOVATIONS INC. (BHIC) gross margin by fiscal year — reported gross profit divided by reported revenue.
57.0%FY2025 · since FY2022: 86.0% → 57.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 57.0% | -14.0 pp |
| FY2024 | 70.9% | -10.1 pp |
| FY2023 | 81.1% | -5.0 pp |
| FY2022 | 86.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More BHIC financial trends
BHIC RevenueBHIC Net incomeBHIC Net marginBHIC Gross profitBHIC Operating incomeBHIC Operating marginBHIC Operating cash flowBHIC Free cash flowBHIC Capital expendituresBHIC Return on equityBHIC Stock buybacksBHIC Dividends paidBHIC Total assetsBHIC Total liabilitiesBHIC Shareholders’ equityBHIC overview →